跳至主要内容
临床试验/JPRN-UMIN000004846
JPRN-UMIN000004846已完成未知

Advanced neuroimaging protocol, including 3T MRI with triple-dose gadoteridol administration, for histopathological characterization of glioma and prediction of the patient's prognosis - Advanced neuroimaging protocol, including MRI with triple-dose gadoteridol administration, for histopathological characterization of glioma

Tokyo Women's Medical University0 个研究点目标入组 40 人开始时间: 2011年1月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)presence of contrast enhancement on T1-weighted 1.5 T MRI after intravenous administration of single-dose (0.2 ml/kg) gadoteridol; these patients will be enrolled into full investigational protocol but their data will be analyzed separately; (2)absence of surgical treatment in TWMU within 1 month after completion of the neuroradiological investigation; (3)establishment of any histpathological diagnosis after resective surgery other than glioma of astrocytic, oligodendroglial, or ependymal origin, neuronal or mixed neuronal-glial neoplasm.

研究者

发起方
Tokyo Women's Medical University

相似试验